Drugs / Clexan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00928213 | Aug 2009 → Dec 2010 | preeclampsia | Ben-Gurion University of the Negev | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT03963336 Comparator | Jul 2017 → Jul 2018 | pseudotumor cerebri | Fayoum University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clexan | “clexan” NCT00928213 ↗1“Clexan” NCT03963336 ↗ |
| Route | Subcutaneous | “Subcutaneous LMWH 1mg/kg/day for 2 weeks” NCT03963336 ↗ |